IMMUNOLOGICAL AND AUTOIMMUNE DISORDERS

View at publisher Summarise with VIRAT
Authors: CEREN YÜCEER PELİOĞLU
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Obesity is now recognized as a chronic, low-grade inflammatory condition rather than merely a metabolic disorder caused by excess fat accumulation. Adipose tissue acts not only as an energy reservoir but also as an active immune organ containing various immune cells, especially macrophages, which mediate complex interactions between metabolic and inflammatory pathways. In healthy adipose tissue, alternatively activated (M2) macrophages support insulin sensitivity and help maintain metabolic balance. However, obesity causes a shift towards classically activated (M1) macrophages, leading to increased secretion of proinflammatory cytokines like tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). These immune changes impair insulin signaling, resulting in insulin resistance and metabolic complications. Leptin, the first hormone discovered to be secreted by fat cells, regulates appetite by acting on the hypothalamus and plays a crucial role in energy homeostasis. Although leptin levels rise in obesity, target cells become re-sistant to its effects. Beyond controlling metabolism, leptin also functions as a powerful immunomodulator linking metabolism and immunity. It boosts innate immune responses by stimulating macrophages, neutrophils, and natural killer (NK) cells, and promotes adaptive immunity by encouraging T-helper 1 (Th1) differentiation while suppressing T-helper 2 (Th2) and regulatory T cell (Tregs) activity. As a result, disrupted leptin signaling can shift immune balance toward a proinflammatory state, increasing the risk of autoimmune diseases. Adiponectin, the most abundant peptide secreted by fat cells, plays a key role in glucose and lipid metabolism, insulin sensitivity, and immune regulation. Its circulating levels are inversely related to obesity, insulin resistance, and cardiovascular risk. Although generally anti-inflammatory, elevated adiponectin levels have been noted in certain autoimmune diseases, indicating a context-dependent dual role influenced by its distinct molecular isoforms. Recent discoveries about adipokines and their roles in immune regulation have greatly advanced knowledge of the link between obesity and autoimmune diseases. Childhood, a vital period for establishing vulnerability to adult-onset conditions, is particularly important here. Growing evidence connects childhood obesity to autoimmune diseases such as systemic lupus erythematosus, psoriatic arthritis, inflammatory bowel disease, and multiple sclerosis. Obesity not only raises the risk but also worsens the severity of various immunological and autoimmune conditions. Notably, this connection is evident even before puberty, highlighting the importance of early intervention in obesity to reduce future burdens of immunerelated disorders.

Fields of Study & Subjects

Adipokines Inflammation and Metabolic Diseases Adipose Tissue and Metabolism Regulation of Appetite and Obesity

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
193–208
Publication date
1 January 2026
Language
EN
Document type
Book chapter